🚀 VC round data is live in beta, check it out!
HBM Healthcare Investments Valuation Multiples
Discover revenue and EBITDA valuation multiples for HBM Healthcare Investments and similar public comparables like Argan SA, AFP Cuprum, L1 Long Short Fund, Ashmore Group and more.
HBM Healthcare Investments Overview
About HBM Healthcare Investments
HBM Healthcare Investments Ltd is a Switzerland-based holding company. The firm actively invests in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. The company holds and manages an international portfolio of companies.
Founded
2001
HQ
Employees
1
Website
Sectors
Financials (LTM)
EV
$2B
HBM Healthcare Investments Financials
HBM Healthcare Investments reported last 12-month revenue of $52M and EBITDA of $20M.
In the same LTM period, HBM Healthcare Investments generated $20M in EBITDA and $20M in net income.
Revenue (LTM)
HBM Healthcare Investments P&L
In the most recent fiscal year, HBM Healthcare Investments reported revenue of $69M and EBITDA of $19M.
HBM Healthcare Investments expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $52M | XXX | $69M | XXX | XXX | XXX |
| EBITDA | $20M | XXX | $19M | XXX | XXX | XXX |
| EBITDA Margin | 39% | XXX | 28% | XXX | XXX | XXX |
| EBIT Margin | 39% | XXX | 28% | XXX | XXX | XXX |
| Net Profit | $20M | XXX | $24M | XXX | XXX | XXX |
| Net Margin | 39% | XXX | 34% | XXX | XXX | XXX |
| Net Debt | — | — | $124M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
HBM Healthcare Investments Stock Performance
HBM Healthcare Investments has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
HBM Healthcare Investments' stock price is $292.86.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -1.1% | XXX | XXX | XXX | $3.60 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHBM Healthcare Investments Valuation Multiples
HBM Healthcare Investments trades at 39.2x EV/Revenue multiple, and 100.5x EV/EBITDA.
EV / Revenue (LTM)
HBM Healthcare Investments Financial Valuation Multiples
As of April 22, 2026, HBM Healthcare Investments has market cap of $2B and EV of $2B.
Equity research analysts estimate HBM Healthcare Investments' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
HBM Healthcare Investments has a P/E ratio of 94.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 39.2x | XXX | 29.9x | XXX | XXX | XXX |
| EV/EBITDA | 100.5x | XXX | 108.8x | XXX | XXX | XXX |
| EV/EBIT | 100.5x | XXX | 108.8x | XXX | XXX | XXX |
| P/E | 94.2x | XXX | 81.4x | XXX | XXX | XXX |
| EV/FCF | 24.5x | XXX | (681.5x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified HBM Healthcare Investments Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
HBM Healthcare Investments Margins & Growth Rates
HBM Healthcare Investments' revenue in the last 12 month grew by 230%.
HBM Healthcare Investments' revenue per employee in the last FY averaged $68.6M, while opex per employee averaged $3.2M for the same period.
HBM Healthcare Investments' rule of 40 is 325% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
HBM Healthcare Investments' rule of X is 695% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
HBM Healthcare Investments Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 230% | XXX | (34%) | XXX | XXX | XXX |
| EBITDA Margin | 39% | XXX | 28% | XXX | XXX | XXX |
| EBITDA Growth | 591% | XXX | (31%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 325% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 695% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $68.6M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $3.2M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 5% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
HBM Healthcare Investments Public Comps
See public comps and valuation multiples for other Asset Management comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| HBM Healthcare Investments | XXX | XXX | XXX | XXX | XXX | XXX |
| Argan SA | XXX | XXX | XXX | XXX | XXX | XXX |
| AFP Cuprum | XXX | XXX | XXX | XXX | XXX | XXX |
| L1 Long Short Fund | XXX | XXX | XXX | XXX | XXX | XXX |
| Ashmore Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Bradespar | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
HBM Healthcare Investments M&A Activity
HBM Healthcare Investments acquired XXX companies to date.
Last acquisition by HBM Healthcare Investments was on XXXXXXXX, XXXXX. HBM Healthcare Investments acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by HBM Healthcare Investments
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialHBM Healthcare Investments Investment Activity
HBM Healthcare Investments invested in XXX companies to date.
HBM Healthcare Investments made its latest investment on XXXXXXXX, XXXXX. HBM Healthcare Investments invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by HBM Healthcare Investments
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout HBM Healthcare Investments
| When was HBM Healthcare Investments founded? | HBM Healthcare Investments was founded in 2001. |
| Where is HBM Healthcare Investments headquartered? | HBM Healthcare Investments is headquartered in Switzerland. |
| How many employees does HBM Healthcare Investments have? | As of today, HBM Healthcare Investments has over 1 employees. |
| Is HBM Healthcare Investments publicly listed? | Yes, HBM Healthcare Investments is a public company listed on SIX Swiss Exchange. |
| What is the stock symbol of HBM Healthcare Investments? | HBM Healthcare Investments trades under HBMN ticker. |
| Who are competitors of HBM Healthcare Investments? | HBM Healthcare Investments main competitors are Argan SA, AFP Cuprum, L1 Long Short Fund, Ashmore Group. |
| What is the current market cap of HBM Healthcare Investments? | HBM Healthcare Investments' current market cap is $2B. |
| What is the current revenue of HBM Healthcare Investments? | HBM Healthcare Investments' last 12 months revenue is $52M. |
| What is the current revenue growth of HBM Healthcare Investments? | HBM Healthcare Investments revenue growth (NTM/LTM) is 230%. |
| What is the current EV/Revenue multiple of HBM Healthcare Investments? | Current revenue multiple of HBM Healthcare Investments is 39.2x. |
| Is HBM Healthcare Investments profitable? | Yes, HBM Healthcare Investments is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of HBM Healthcare Investments? | HBM Healthcare Investments' last 12 months EBITDA is $20M. |
| What is HBM Healthcare Investments' EBITDA margin? | HBM Healthcare Investments' last 12 months EBITDA margin is 39%. |
| What is the current EV/EBITDA multiple of HBM Healthcare Investments? | Current EBITDA multiple of HBM Healthcare Investments is 100.5x. |
| What is the current FCF of HBM Healthcare Investments? | HBM Healthcare Investments' last 12 months FCF is $84M. |
| What is HBM Healthcare Investments' FCF margin? | HBM Healthcare Investments' last 12 months FCF margin is 160%. |
| What is the current EV/FCF multiple of HBM Healthcare Investments? | Current FCF multiple of HBM Healthcare Investments is 24.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.